Drug Trial Radar · NCT02171988
Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
Last checked: Nov 19, 2026Latest source record: Apr 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Mar 2014
Primary completion
Feb 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- Seoul National University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 24, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 15 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to investigate effect of medical treatment and prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
Conditions
- Postural Orthostatic Tachycardia Syndrome
Interventions
PropranololDrug
Start propranolol 10mg bid, and then dose up to 20mg bid after one month if tolerable
BisoprololDrug
Start bisoprolol 2.5mg qd P.O, and then dose up to 5mg qd. if tolerable
Propranolol+pyridostigmineDrug
Start propranolol+pyridostigmine 10mg bid +30mg bid, and then dose up to 20mg bid+30mg bid. if tolerable.
Bisoprolol+pyridostgmineDrug
Start bisoprolol+pyridostgmine 2.5mg qd+30mg bid, and then, dose up to 5mg qd+30mg bid. if tolerable
Primary outcomes
What the sponsor says the trial is designed to measure.
- The change of the subjective symptom survey result after 3-month medical treatment.Time frame: 3 month after medical treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seoul National University Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.